Scalable Synthesis and Purification of Acetylated Phosphatidyl Choline Headgroup

Article abstract of DOI:10.1021/acs.oprd.6b00261

The acetylated headgroup of the most abundant mammalian phospholipid, 1,2-diacetyl-3-sn-phosphatidyl choline (DAcPC), has several important applications in research. For instance, it can be dissolved in the same amount of water as in the fluid PC bilayer, to create a surrogate of a PC headgroup stratum, for studying the solvation of small molecules and the influence of their structure on the process. In contrast to PC derivatives with longer acyl chains, DAcPC does not self-aggregate, rendering the aqueous solution homogeneous and suitable for simplified analyses of interactions of molecules with the headgroups. Several studies have been published where DAcPC was used in a crudely purified form. Here we describe a one-step preparation of DAcPC from commercially available bulk chemicals and purification of the product by crystallization and washing. The process gives a good yield and is easily scalable. The availability of enantiopure, crystalline DAcPC could open the door to more extensive biochemical, pharmacological, and nutritional studies of this interesting chemical.

Full text of DOI:10.1021/acs.oprd.6b00261

Subscriber access provided by UB + Fachbibliothek Chemie | (FU-Bibliothekssystem)
Full Paper
Scalable Synthesis and Purification of
Acetylated Phosphatidyl Choline Headgroup
Rajesh Subramaniam, Ramesh Jagadeesan, Iswarya Mathew, Yana Cen, and Stefan Balaz
Org. Process Res. Dev., Just Accepted Manuscript • DOI: 10.1021/acs.oprd.6b00261 • Publication Date (Web): 24 Jan 2017
Downloaded from http://pubs.acs.org on January 29, 2017
Just Accepted
“Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted
online prior to technical editing, formatting for publication and author proofing. The American Chemical
Society provides “Just Accepted” as a free service to the research community to expedite the
dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts
appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been
fully peer reviewed, but should not be considered the official version of record. They are accessible to all
readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered
to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published
in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just
Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor
changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers
and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors
or consequences arising from the use of information contained in these “Just Accepted” manuscripts.
Organic Process Research & Development is published by the American Chemical
Society. 1155 Sixteenth Street N.W., Washington, DC 20036
Published by American Chemical Society. Copyright © American Chemical Society.
However, no copyright claim is made to original U.S. Government works, or works
produced by employees of any Commonwealth realm Crown government in the course
of their duties.

Page 1 of 19
Organic Process Research & Development
1
2
3
4
5
6
7
8
9
Scalable Synthesis and Purification of Acetylated
Phosphatidyl Choline Headgroup
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Rajesh Subramaniam,† Ramesh Jagadeesan,‡ Iswarya Mathew,† Yana Cen,† and Stefan Balaz*,†
†Department of Pharmaceutical Sciences, Vermont Campus, Albany College of Pharmacy and
Health Sciences, 261 Mountain View Drive, Colchester, Vermont 05446, Unites States
‡Pharmaceutical Development Unit, Kemwell Biopharma Pvt Ltd, 34 Tumkur Road, T-
Begur, Nelamangala, Bangalore Rural- 562123, India
ACS Paragon Plus Environment
1

Organic Process Research & Development
Page 2 of 19
1
2
3
4
Table of Contents Graphic
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
ACS Paragon Plus Environment
2

Page 3 of 19
Organic Process Research & Development
1
2
3
4
5
6
7
8
9
ABSTRACT: The acetylated headgroup of the most abundant mammalian phospholipid, 1,2-
diacetyl-3-sn-phosphatidyl choline (DAcPC), has several important applications in research. For
instance, it can be dissolved in the same amount of water as in the fluid PC bilayer, to create a
surrogate of a PC headgroup stratum, for studying solvation of small molecules and the influence
of their structure on the process. In contrast to PC derivatives with longer acyl chains, DAcPC
does not self-aggregate, rendering the aqueous solution homogeneous and suitable for simplified
analyses of interactions of molecules with the headgroups. Several studies have been published
where DAcPC was used in a crudely purified form. Here we describe a one-step preparation of
DAcPC from commercially available bulk chemicals and purification of the product by
crystallization and washing. The process gives a good yield and is easily scalable. The
availability of enantiopure, crystalline DAcPC could open the door to more extensive
biochemical, pharmacological, and nutritional studies of this interesting chemical.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
KEYWORDS: phosphatidyl choline (PC) headgroup, PC headgroup stratum surrogate, drug-
headgroup interactions, drug solvation in headgroup stratum, PC bilayer, bilayer accumulation,
bilayer transport
ACS Paragon Plus Environment
3

Organic Process Research & Development
Page 4 of 19
1
2
Phosphatidylcholine (PC) derivatives have been widely used to study bilayer properties,1
protein-lipid adducts,2 and PC interactions with aromatic amino acids,3 to carry drug loads,4 to
identify,5 monitor,6 and inhibit7 enzymes, to analyze enzyme mechanisms, to modulate cell
activity,9 to develop cosmetics10 and coatings,11 to enable imaging,12 therapy,13 and gene
delivery,14 and to perform total syntheses of natural products.15 We are interested in using a PC
derivative to study accumulation of drugs and drug-like compounds in the headgroup stratum of
bilayers of biological membranes, and to analyze the influence of drug structure on the process.16
Drug interactions with the headgroup and core strata are weak and difficult to measure because
of the microscopic dimensions. To facilitate the measurements, an abstract ‘split’ of the bilayer
into phases of homogeneous compositions, representing the headgroups and the core, helps
design surrogate systems, which can be produced and used in macroscopic quantities, and
analyzed using conventional analytical techniques.
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Surrogate systems have been widely used to investigate drug transport and accumulation
phenomena for more than a century. Several solvent systems have been used to mimic the
bilayer, initially as a whole and later as individual bilayer strata. Interestingly, the well-
established reference solvent, wet 1-octanol, was mostly used as a bilayer surrogate17 but also
supposed to represent the headgroups in some studies.18 A PC derivative should be a superb
surrogate for the headgroups because PC represents the predominant weight fraction of lipids in
human bilayers: 42-49 % for skeletal muscle, heart, and liver, and 41% for brain.19 The solvation
properties of the bilayer core can be emulated by n-hexadecane20 and other alkanes21 or alkenes22
because of similar densities and composition.23
Fluid PC bilayers are most frequently used in drug accumulation and transport experiments.
Based on experimental24 and computational25 analyses, they contain 6-16 water molecules per
ACS Paragon Plus Environment
4

Page 5 of 19
Organic Process Research & Development
1
2
3
4
5
6
7
8
9
headgroup, depending on the fatty acid chains, pressure, and temperature. This means that a good
headgroup surrogate is a PC derivative that has high aqueous solubility in molar range and forms
homogeneous solutions even at high concentrations. Since commercially available di-n-
propanoyl PC has the critical micellar concentration equal to 450 mM,26 and the diformyl PC
would provide additional H-bonding not found in PC,27 diacetyl phosphatidyl choline (DAcPC)
was an obvious candidate to examine.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Despite ample literature precedence for the synthesis of PC lipid derivatives, a reliable and
scalable single-step process for the synthesis of DAcPC has not yet been identified. The reported
procedures typically incorporate a hydrophobic carboxylic acid to facilitate the purification of
the final compound. Syntheses of PC derivatives (Scheme 1) employed either L-α-
glycerophosphocholine (GPC - middle), a monoester derivative of GPC (top) or a diester
derivative of glycerol, into which the PC moiety was incorporated (bottom).
Scheme 1. Retrosynthetic analysis of PC derivatives. The R1 and R2 substituents may be
identical.
ACS Paragon Plus Environment
5

Organic Process Research & Development
Page 6 of 19
1
2
3
4
5
6
7
8
9
The PC derivatives (Scheme 1) containing hydrophobic fragments could be purified by column
chromatography and similar techniques. Typically, the compounds were prepared in small
quantities - milligrams to few grams per reaction. However, for large scale synthesis (100 g to 1
kg), these purification approaches may not be ideal.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For example, D’Arrigo et al28 reported a procedure to make mixed short/long chain PCs in a
two-step process. GPC was first converted to cyclic stannylene derivatives, followed by the
treatment with the first acyl chloride to obtain the lyso-phospholipid, which was further acylated
with acid anhydride. The process typically uses a long chain fatty acid to facilitate purification of
the product among other synthetic goals. Similarly, Rosseto et al29 performed a multistep
synthesis of mixed PCs in which the polar phosphocholine group was incorporated in the last
step. However, the final product purification likewise seemed to be facilitated by the
hydrophobic carboxylic esters. This was also the case for the synthesis protocol of Roodsari et
al30 in which the PC was incorporated as the last step.
Basheer et al described an enzymatic production of phospholipids in a patent filing31 but the
process was optimized for fatty acids. Park et al32 reported a multi-step synthetic procedure for
DAcPC starting from glycidol that was converted into 1-O-benzyl ether derivative of glycerol.
The hydroxyl groups at C-2 and C-3 of glycerol were then acetylated. The diacetylated product
was converted into DAcPC in three steps, and DAcPC was purified by column chromatography.
However, since we needed to produce DAcPC in large quantities (preferably larger than 100
gram batches), this procedure32 didn’t seem feasible as we had observed severe tailing of DAcPC
during column purification (see below).
Puricelli33 prepared DAcPC in two steps. First, 2-chloro-2-oxa-1,3,2-dioxaphospholane was
condensed with L-1,2-di-O-acetylglycerol in ether in presence of triethylamine at room
ACS Paragon Plus Environment
6

Page 7 of 19
Organic Process Research & Development
1
2
3
4
5
6
7
8
9
temperature. Then the condensate was reacted with excess trimethylamine under pressure at 1.5
atmospheres and 50 ºC to obtain DAcPC. The crude product was purified in a multistep process
that involved filtering over carbon, ion exchange, vacuum concentration and recrystallization
from acetone/alcohol mixtures. Alternatively, the crude DAcPC was subjected to column
chromatography, a carbon treatment to remove color, and recrystallization from hydrated alcohol
mixture (3% water in methanol). However, the author33 did not describe the synthesis of α-1,2-
di-O-acetylglycerol or its source. A literature search shows the racemic compound to be
commercially available in gram quantities and its synthesis most likely involves a multistep
process as described by Park et al.32
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
At the first attempt, we modified a procedure reported by Ichihara et al34 to prepare DAcPC at
a small scale. In the modified procedure, GPC adsorbed on to kieselguhr was suspended in dry
chloroform and treated with excess acetic anhydride (2.5 molar equivalents) in presence of N,N-
dimethylaminopyridine (DMAP) for 60 h. Although the procedure showed complete
consumption of GPC, this reaction cannot be easily scaled up. For example, a gram-scale
reaction needed more than a liter of methanol to wash DAcPC off the kieselguhr. A second
challenge in the process was to isolate DAcPC from acetic acid byproduct and DMAP as the
product seemed to have severe tailing when column chromatography was attempted with even
100% methanol containing 5% ammonia (~7 L solvent required to recover ~650mg DAcPC by
normal column chromatography).
To satisfy the needs of researchers using DAcPC in their studies, including our laboratory, we
developed a single step, scalable synthesis of DAcPC from commercially available compounds
and purification of the product by distillation, crystallization, and washing. The details are
summarized in this report.
ACS Paragon Plus Environment
7

Organic Process Research & Development
Page 8 of 19
1
2
3
4
Results and Discussion
5
6
7
8
Synthesis. The one-pot, scalable DAcPC synthesis using commercially available GPC, acetic
anhydride (Ac2O), and N,N-diisopropylethylamine (DIPEA) was performed at 50-60 °C for 5
days (Scheme 2). The used GPC was enantiopure, as confirmed by specific optical rotation,
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
α
25 = - 2.6 (c 2.7 in water), which is in good agreement with published data.35
[ ]
D
Scheme 2. DAcPC synthesis from GPC using Ac2O and DIPEA.
In a typical reaction, about 100 g of GPC was vacuum dried in a 500 mL Teflon® oven-dried
flask, Ac2O and DIPEA were added (4 molar and 3 molar equivalents, resp.), and the mixture
was stirred at 55 oC for 5 days. The viscous GPC layer, adhering to the flask, gradually vanished,
indicating the completion level of the reaction. Simultaneously, the mixture separated into two
phases: a brown bottom layer containing most of the product, and a clear, almost colorless upper
layer containing most of ammonium acetate. After disappearance of the GPC layer, the reaction
mixture was stirred for additional 24 h.
Purification. Upon reaction completion (4-6 days), excess reagents and byproducts were
o
o
stripped off under high vacuum at 110 C (6 h) and 120 C (2 h) in a glass round-bottom flask
with constant stirring. The resulting reddish brown waxy solid was dissolved in 2 molar
o
equivalents of water by stirring in a rotary evaporator at 80 C without any vacuum. The
resulting homogenous dark reddish brown solution was transferred into a 1 L Erlenmeyer flask,
mixed with 1 L of acetone, and set for crystallization overnight at room temperature. DAcPC
ACS Paragon Plus Environment
8

Page 9 of 19
Organic Process Research & Development
1
2
crystallizes out as yellowish monohydrate (as inferred from 1H NMR spectra – see below) in 50-
80% yield in the first crop (m.p. = 96-98 ºC). The purity of the initial product was characterized
by HPLC as 94 – 95 % (peak area ratio).
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Apparently, a significant amount of impurities adhered to the surface of the crystals because
they could be removed by washing by acetone or hexane with a weight loss 2-4 %, resulting in
whitening of the crystals. The dried product was dissolved in a minimum amount of water and
recrystallized from acetone, with 90 – 94 % yield. Repeated washing and crystallization provided
better than 99 % purity, as determined by HPLC. For experiments using aqueous solutions, the
impurities could also be extracted by partitioning into alkanes, while DAcPC remained in the
aqueous solution. The impurities showed UV absorbance between 250 and 280 nm, DAcPC
1
13
absorbs below 250 nm. The H, C, and ATR-IR spectra correspond with the DAcPC structure
1
and are in good agreement with previously reported data.32 The H NMR spectra and peak
assignments for lyophilized DAcPC are in Supporting Information.
Water Content. The exact water content of crystalline DAcPC is important for preparing the
accurately defined aqueous solutions, serving as surrogates of bilayer headgroups under different
conditions (temperature, fatty acid chains of PC, admixtures). DAcPC crystallizes as a
monohydrate, as shown by a comparison of 1H NMR spectra of purified DAcPC in CDCl3 before
and after lyophilization, which removes the water completely. If crystallized DAcPC
monohydrate is left standing for days or weeks without desiccation, the water content increases
to almost two molecules of water per DAcPC, although the crystals do not change visibly in the
process. For such crystals, thermogravimetric (TGA) analysis in the nitrogen atmosphere showed
that the major drop in weight occurred between 77.64 ºC and 117.47 ºC. This weight loss,
attributed to the loss of water from the crystals, was 7.9 %, which was more than what was
ACS Paragon Plus Environment
9

Organic Process Research & Development
Page 10 of 19
1
2
3
4
5
6
7
8
9
expected for a monohydrate (5.0 %). The sample was decomposed at about 220 ºC. The Karl
Fisher titration of the air-exposed DAcPC crystals showed the water content of 9.3 %, almost
double that of monohydrate.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Crystallinity. The X-ray diffraction analysis showed four peaks with the relative intensity of
more than 90 % and numerous smaller peaks. The peaks were not analyzed in detail but their
presence confirmed the crystalline nature of isolated DAcPC solids. The DSC analysis of air-
exposed crystals showed two asymmetric endothermic peaks. The larger peak at 96.97 ºC
(melting point) started at about 50 ºC, pointing to the possibility of gradual loss of water. The
smaller peak at 142.82 ºC could indicate a crystal form transition.
25
Enantiomer Analysis. Aqueous solutions of DAcPC exhibit specific optical rotation
α
=
[ ]
D
+6.51 (c 3.4 in water). This value is in good agreement with the data for 1,2-diacyl-3-sn-
phosphatidyl cholines with different fatty acids, having
methanol/chloroform mixtures.30,36 The published32 value
α
25 values from +5.10 to +7.02 in
[ ]
D
α
[ ]
25 = + 12.11 (c 1.8 in methanol) for
D
DAcPC seems to be a bit out of this range. To analyze whether DAcPC is a mixture of
enantiomers, a HPLC analysis with a chiral column was used. An isocratic protocol using the
ChiralPak IC-3 column with ethanol as eluent did not show the presence of two enantiomers.
These data indicate that synthesized and purified DAcPC is enantiopure.
EXPERIMENTAL SECTION
Materials. L-α-glycerophosphocholine (GPC) was procured from Waterstone Technologies,
Carmel, IN in 2.5 kg batches. Acetic anhydride (Ac2O) and N,N-diisopropylethylamine (DIPEA)
were purchased from Alfa Aesar in liter quantities, and used as received.
ACS Paragon Plus Environment
10

Page 11 of 19
Organic Process Research & Development
1
2
3
4
5
6
7
8
9
1,2-Diacetyl-3-sn-Phosphatidyl Choline. About 100 g of GPC was placed in a 500 mL
round-bottom, oven-dried Teflon® flask. GPC was then dried under high vacuum created by an
Edwards model RV8 pump (2.0 x 10-3 mbar ultimate total pressure, as per company
specifications) over phosphorus pentoxide for at least 5 hrs. About 4 molar equivalents of Ac2O
and 3 molar equivalents of DIPEA were added to GPC. The molar equivalence was calculated
based on the weight of GPC after vacuum drying. The reaction mixture was stirred at 55 ºC for
4-6 days using an in-house built overhead stirrer. At reaction completion, the viscous GPC was
no longer seen adhering to the flask, and the reaction mixture was biphasic, with a reddish brown
bottom layer and a clear, faintly yellow to colorless, upper layer. The reaction mixture was
transferred into a glass round-bottom flask and distilled 6 h under high vacuum created by an
Edwards model RV8 pump at 110 ºC with constant stirring provided by a magnetic stir bar. The
temperature was raised briefly (~2 h) to 120 ºC to distill off the DIPEA acetate salt to obtain a
reddish brown waxy solid. The solid was dissolved in 2 molar equivalents of water by stirring
the distillation flask in a rotary evaporator at 80 ºC without any vacuum. Once a homogenous
solution was obtained, the dark reddish brown solution was transferred into a 1 L Erlenmeyer
flask. About 1 L of acetone was added to this solution, and set for crystallization overnight at
room temperature. DAcPC crystallizes out as monohydrate with 50-80% yield in the first crop
having 94 – 95 % purity (HPLC peak area ratio).
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Washing with acetone or hexane resulted in whitening of the crystals, with a weight loss of 2-4
%. Crude DAcPC (30 g) was placed in a 500 mL Erlenmeyer flask and dissolved, with
sonication, in minimum quantity of water (about 9 mL). Acetone (500 mL) was added to the
flask and the solution was set for recrystallization (48-72 h) in the hood at room temperature.
The solid DAcPC was collected by decantation and washed thrice with 60 mL of acetone each
ACS Paragon Plus Environment
11

Organic Process Research & Development
Page 12 of 19
1
2
3
4
5
6
7
8
9
time. The recrystallized DAcPC was dried in an oven at 37 ºC for 24-48 h. The yield was 90-94
%. The recrystallization process was repeated in case any impurity peak was observed in the UV
or 1H NMR spectra.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
1
The product was characterized as follows: m.p. = 96-98 ºC; H NMR (CDCl3, 500 MHz,
Brucker): after synthesis - δ 2.04 (s, 3H), 2.06 (s, 3H), 3.35 (s, 9H), 3.79 (m, 2H), 3.93 (m, 2H),
4.13 (dd, J =6.5, 12.0 Hz, 1H), 4.20 (m, 2H), 4.27 (m, 2H – water), 4.35 (dd, J = 3.0, 12.0 Hz,
1H), 5.17 (m, 1H); after lyophilization (see Supplementary Information) - δ 2.00 (s, 3H), 2.02 (s,
3H), 3.34 (s, 9H), 3.78 (m, 2H), 3.90 (m, 2H), 4.10 (dd, J = 6.9, 12.1 Hz, 1H), 4.25 (m, 2H), 4.31
13
(dd, J = 3.3, 12.1 Hz, 1H), 5.13 (m, 1H); C NMR: (CD3OD, 125 MHz, Bruker) δ 20.6, 20.9,
54.7, 60.5, 63.7, 64.8, 67.5, 72.0, 172.1, 172.4 ppm; MS: (ESI, Agilent 6130 single quadrupole)
molecular ion calculated m/z 341.2946 (M), found 341.3 (M) and 364.1 (M + Na+); ATR-IR
(Alpha-E, Bruker) CH3 (s) 2960.44, CH2 (s) and CH (s) 2892.01, CH2 (b) and CH (b) 1485.89
and 1364.30, C=O (s) 1720.86, C-O-C (s) 1049.00, OH (s) in water 3391.61, P=O (s) 1380.49,
P-O-C (s) 972.06 cm-1; XRD (PANalytical X’Pert Pro, CuKa radiation, 40 kV, 40mA) 6.764,
15.394, 16.892, 20.195 °2Th.
HPLC Analyses. Two protocols were used: one with the main aim to determine the purity of
the product and the other for characterizing enantiomer composition. The analyses were run on
Waters e2695 HPLC with 2998 PDA detector. The DAcPC sample concentrations were 10-20
mg/mL, volume 10-20 ꢀL, and temperature 25 ºC. The analyses lasted 15-25 min and the
DAcPC elution time was 11-12 min.
The purity determination procedure used 250 mm × 4.6 mm, 3.5 ꢀm, C18 Waters XBridge
column. The protocol was extensively optimized to ensure that: (1) all peaks are separated; (2)
the tailing factor of the DAcPC peak is minimal (<2.0); (3) the USP plate count for the DAcPC
ACS Paragon Plus Environment
12

Page 13 of 19
Organic Process Research & Development
1
2
3
4
5
6
7
8
9
peak is more than 10,000; and (4) the RSD of the DAcPC peak area for five replicate injections
is less than 2 %. The Limit of Detection and the Limit of Quantitation were determined by the
noise ratio method as 7.5 ppm and 20 ppm. The linearity was established for the DAcPC
concentrations between 20 ppm and 3000 ppm. The procedure can be used to assess the purity of
prepared DAcPC based on the ratio of the DAcPC area and total area. Two mobile phases were
used: Milli-Q produced water with pH adjusted to 2.5 with ortho phosphoric acid (A) and
acetonitrile (B). The gradient program was optimized as follows (time in min: % A, % B): 0: 99,
1; 3.5: 97, 3; 5.5: 97, 3; 6.5: 94, 6; 10.0: 94, 6; 12.0: 99, 1; 15.0: 99, 1; with the flow rate 1.0
mL/min.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
The enantiomer characterization procedure was run in isocratic mode. The ChiralPak IC-3
(250 mm x 4.6 mm), 3µm column and ethanol as eluent were used.
Attenuated Total Reflectance Infrared Analysis. A sample of crystallized DAcPC (10.0 mg)
was placed on the ATR crystal and scanned for the frequencies from 4000 cm-1 to 650 cm-1
(Alpha–E with software OPUS version 7.0, Bruker). The frequencies are listed as stretching (s)
or bending (b).
X-Ray Diffraction. The crystalline DAcPC sample (500 mg) was used to make the pure
material pellet, which was analyzed in a wide angle X-ray diffractometer (X’Pert Pro,
PANanalytical). The peaks with the relative intensity above 90 % are listed. Many more peaks
were observed.
Thermogravimetry. The crystalline DAcPC (9.712 mg) in a platinum crucible pan was placed
into a TA Q-500 TGA analyzer, equilibrated at 30 ºC, and heated at 10 ºC/min to 250 ºC. The
weight was taken in 0.5 sec intervals. The flow of nitrogen over the sample was 60 mL/min and
over the balance 40 mL/min.
ACS Paragon Plus Environment
13

Organic Process Research & Development
Page 14 of 19
1
2
3
4
5
6
7
8
9
Differential Scanning Calorimetry. A pan was filled with the crystalline DAcPC (5.10 mg),
lidded, and pressed using the sample encapsulating press. A crimped empty sample pan and lid
were used as a reference. The sample was placed in the TA Q-2000 DS calorimeter with the
nitrogen flow 50 mL/min and was equilibrated at 30 ºC. The temperature was raised to 250 ºC
and then decreased back to 30 ºC, both at 10 ºC/min. The heat flow was measured in 0.5 sec
intervals.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Karl Fisher Titration was used to determine the water content of air-exposed crystals. The
DAcPC (about 100 mg) was transferred to the vessel of the autotitrator (Metrohm Titranido-905
with Ti stand 803, software Tiamo 2.4). The titration was run in duplicate.
Polarimetry. Two aqueous concentrations of DAcPC (34 and 102 g/L) were analyzed using
Advanced Research Instruments PA-IR polarimeter at room temperature. The results showed
25
small nonlinearity in the dependence of specific optical rotation on concentration (the
α
[ ]
D
values +6.51 and +6.02 for the lower and higher concentration, respectively), so the value for the
lower concentration was reported.
AUTHOR INFORMATION
Corresponding Author
*E-mail: stefan.balaz@acphs.edu
Notes. The authors declare no competing financial interest.
ACS Paragon Plus Environment
14

Page 15 of 19
Organic Process Research & Development
1
2
3
4
ACKNOWLEDGEMENTS
5
6
7
8
9
The authors thank to Dr. Senthil Natesan for fruitful discussions leading to the expansion of the
palette of characterization methods. The research was in part supported by the NIH grant
GM80508.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Supporting Information
The Supporting Information is available free of charge on the ACS Publications website at
DOI:
1H NMR spectrum of lyophilized 1,2-diacetyl-3-sn-phosphatidyl choline in CDCl3 with peak
assignment.
Reference List
1. (a) Cui, J.; Lethu, S.; Yasuda, T.; Matsuoka, S.; Matsumori, N.; Sato, F.; Murata, M.
Bioorg. Med. Chem. Lett. 2015, 25, 203-206. (b) Gagnon, M. C.; Turgeon, B.; Savoie, J. D.;
Parent, J. F.; Auger, M.; Paquin, J. F. Org. Biomol. Chem. 2014, 12, 5126-5135. (c) Krause, M.
R.; Daly, T. A.; Almeida, P. F.; Regen, S. L. Langmuir 2014, 30, 3285-3289. (d) Yasuda, T.;
Kinoshita, M.; Murata, M.; Matsumori, N. Biophys. J. 2014, 106, 631-638.
2.
(a) Gubbens, J.; Ruijter, E.; de Fays, L. E., V; Damen, J. M.; de Kruijff, B.; Slijper, M.;
Rijkers Dirk, T. S.; Liskamp Rob, M. J.; de Kroon, K. A., Chem. Biol. 2009, 16, 3-14. (b)
ACS Paragon Plus Environment
15

Organic Process Research & Development
Page 16 of 19
1
2
3
4
Tallman, K. A.; Kim, H. Y.; Ji, J. X.; Szapacs, M. E.; Yin, H.; McIntosh, T. J.; Liebler, D. C.;
5
6
Porter, N. A. Chem. Res. Toxicol. 2007, 20, 227-234.
7
8
9
3.
(a) Sanderson, J. M.; Whean, E. J. Phys. Chem. Chem. Phys. 2004, 6, 1012-1017. (b)
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Sanderson, J. M. Org. Biomol. Chem. 2007, 5, 3276-3286.
4.
(a) Li, Q.; Tian, Y.; Li, D.; Sun, J.; Shi, D.; Fang, L.; Gao, Y.; Liu, H. Biomaterials 2014,
35, 6462-6472. (b) Bayer, A. M.; Alam, S.; Mattern-Schain, S. I.; Best, M. D. Chem. - Eur. J.
2014, 20, 3350-3357.
5.
Long, J. Z.; Cisar, J. S.; Milliken, D.; Niessen, S.; Wang, C.; Trauger, S. A.; Siuzdak, G.;
and Cravatt, B. F. Nat. Chem. Biol. 2011, 7, 763-765.
6.
(a) Popov, A. V.; Mawn, T. M.; Kim, S.; Zheng, G.; Delikatny, E. J. Bioconjugate Chem.
2010, 21, 1724-1727. (b) El Alaoui, M.; Noiriel, A.; Soulere, L.; Grand, L.; Queneau, Y.;
Abousalham, A. Anal. Chem. 2014, 86, 10576-10583.
7.
Falconi, M.; Ciccone, S.; D'Arrigo, P.; Viani, F.; Sorge, R.; Novelli, G.; Patrizi, P.;
Desideri, A.; Biocca, S. Biochem. Biophys. Res. Commun. 2013, 438, 340-345.
8.
Liu, W.; Porter, N. A.; Schneider, C.; Brash, A. R.; Yin, H. Free Radical Biol. Med.
2011, 50, 166-178.
9.
Egger, J.; Bretscher, P.; Freigang, S.; Kopf, M.; Carreira, E. M. Angew. Chem., Int. Ed.
2013, 52, 5382-5385.
10.
11.
Pifferi, G.; Anzaghi, P.; Stefli, R. 2002, EP2641[2002072591]
Dietz, U.; Nubbemeyer, U. Germany. 2012, EP60773[2012168342].
ACS Paragon Plus Environment
16

Page 17 of 19
Organic Process Research & Development
1
2
3
4
12.
Ng, K. K.; Shakiba, M.; Huynh, E.; Weersink, R. A.; Roxin, A.; Wilson, B. C.; Zheng, G.
5
6
ACS Nano 2014, 8, 8363-8373.
7
8
9
13.
14.
He, C.; Liu, D.; Lin, W. ACS Nano 2015, 9, 991-1003.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Prata, C. A. H.; Li, Y.; Luo, D.; McIntosh, T. J.; Barthelemy, P.; Grinstaff, M. W. Chem.
Commun. 2008, 1566-1568.
15.
(a) Duclos, R. I., Jr. Chem. Phys. Lipids 2010, 163, 102-109. (b) Acharya, H. P.;
Kobayashi, Y. Angew. Chem., Int. Ed. 2005, 44, 3481-3484.
16.
(a) Natesan, S.; Lukacova, V.; Ming, P.; Subramaniam, R.; Lynch, S.; Wang, Z.;
Tandlich, R.; Balaz, S. Mol. Pharmaceutics 2014, 11, 3577-3595. (b) Lukacova, V.; Natesan, S.;
Peng, M.; Tandlich, R.; Wang, Z.; Lynch, S.; Subramaniam, R.; Balaz, S. Mol. Pharmaceutics
2013, 10, 3684-3696. (c) Lukacova, V.; Peng, M.; Tandlich, R.; Hinderliter, A.; Balaz, S.
Langmuir 2006, 22, 1869-1874.
17.
(a) Collander, R. Acta Chem. Scand. 1951, 5, 774-780. (b) Hansch, C.; Fujita, T. J. Am.
Chem. Soc. 1964, 86, 1616-1626. (c) Leo, A.; Hansch, C.; Elkins, D. Chem. Rev. 1971, 71, 525-
616.
18.
(a) Xiang, T. X.; Anderson, B. D. J. Pharm. Sci. 1994, 83, 1511-1518. (b) Wimley, W.
C.; White, S. H. Nat. Struct. Biol. 1996, 3, 842-848.
19.
Geigy Scientific Tables, 8th ed.; Ciba-Geigy Corporation: West Caldwell, NJ, 1986; pp 1-
Scheuplein, R. J.; Blank, I. H.; Brauner, G. J.; MacFarlane, D. J. J. Invest. Dermatol.
300.
20.
1969, 52, 63-70.
ACS Paragon Plus Environment
17

Organic Process Research & Development
Page 18 of 19
1
2
3
4
21.
Chikhale, E. G.; Ng, K. Y.; Burton, P. S.; Borchardt, R. T. Pharm. Res. 1994, 11, 412-
5
6
419.
7
8
9
22.
23.
24.
Xiang, T. X.; Anderson, B. D. J. Membr. Biol. 1994, 140, 111-122.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Marrink, S. J.; Berendsen, H. J. C. J. Phys. Chem. 1994, 98, 4155-4168.
(a) Balgavy, P.; Dubnickova, M.; Kucerka, N.; Kiselev, M. A.; Yaradaikin, S. P.;
Uhrikova, D. Biochim. Biophys. Acta 2001, 1512, 40-52. (b) Barry, J. A.; Gawrisch, K.
Biochemistry 1994, 33, 8082-8088. (c) Hristova, K.; White, S. H. Biophys. J. 1998, 74, 2419-
2433.
25.
Tieleman, D. P.; Marrink, S. J.; Berendsen, H. J. Biochim. Biophys. Acta 1997, 1331,
235-270.
26.
27.
28.
Martin, S. F. and Pitzer, G. E. BBA Biomembr. 2000, 1464, 104-112.
Desiraju, G. R. Acc. Chem. Res. 1996, 29, 441-449.
D'Arrigo, P.; Fasoli, E.; Pedrocchi-Fantoni, G.; Rossi, C.; Saraceno, C.; Tessaro, D.;
Servi, S. Chem. Phys. Lipids 2007, 147, 113-118.
29.
30.
31.
32.
Rosseto, R.; Bibak, N.; Hajdu, J. Org. Biomol. Chem. 2006, 4, 2358-2360.
Roodsari, F. S.; Wu, D.; Pum, G. S.; Hajdu, J. J. Org. Chem. 1999, 64, 7727-7737.
Basheer, S.; Zuabi, R.; Shulman, A.; Mar-Chaim, N. 2002-IL344[2002090560].
Park, J. M.; De Castro, K. A.; Ahn, H.; Rhee, H. Bull. Korean Chem. Soc. 2010, 31,
2689-2691.
ACS Paragon Plus Environment
18

Page 19 of 19
Organic Process Research & Development
1
2
3
4
5
6
33.
34.
Puricelli, L. 1992, EP-102731[502357].
Ichihara, K.; Iwasaki, H.; Ueda, K.; Takizawa, R.; Naito, H.; Tomosugi, M. Chem. Phys.
7
8
9
Lipids 2005, 137, 94-99.
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
35.
Milne, G. W. A. Drugs: Synonyms and Properties, Ashgate Publishing Company,
Brookfield, VT, 2000; p. 1280. (b) Baer, E.; Kates, M. J. Am. Chem. Soc. 1948, 70, 1394-1399.
36.
(a) Baer, E.; Buchnea, D.; Newcombe, A. E. J. Am. Chem. Soc. 1956, 78, 232-257. (b)
Bibak, N.; Hajdu, J. Tetrahedron Lett. 2003, 44, 5875-5877. (c) Baer, E.; Kates, M. J. Am.
Chem. Soc. 1950, 72, 942-949. (d) Hanahan, D. J. J. Biol. Chem. 1954, 211, 321-325.
ACS Paragon Plus Environment
19